HK1095092A1 - Amino substituted diaryl [a,d] cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders - Google Patents
Amino substituted diaryl [a,d] cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disordersInfo
- Publication number
- HK1095092A1 HK1095092A1 HK07102395.0A HK07102395A HK1095092A1 HK 1095092 A1 HK1095092 A1 HK 1095092A1 HK 07102395 A HK07102395 A HK 07102395A HK 1095092 A1 HK1095092 A1 HK 1095092A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- analogs
- methods
- cycloheptene
- treatment
- amino substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53192703P | 2003-12-22 | 2003-12-22 | |
US54809004P | 2004-02-24 | 2004-02-24 | |
US54860404P | 2004-02-27 | 2004-02-27 | |
PCT/US2004/043224 WO2005063254A2 (en) | 2003-12-22 | 2004-12-21 | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1095092A1 true HK1095092A1 (en) | 2007-04-27 |
Family
ID=34743692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07102395.0A HK1095092A1 (en) | 2003-12-22 | 2007-03-05 | Amino substituted diaryl [a,d] cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
Country Status (23)
Country | Link |
---|---|
US (5) | US7550454B2 (de) |
EP (2) | EP1696931B1 (de) |
JP (1) | JP2007534656A (de) |
KR (1) | KR101157881B1 (de) |
CN (1) | CN101962369A (de) |
AT (1) | ATE426405T1 (de) |
AU (1) | AU2004308955B2 (de) |
BR (1) | BRPI0417749A (de) |
CA (1) | CA2550735A1 (de) |
CY (1) | CY1109171T1 (de) |
DE (1) | DE602004020263D1 (de) |
DK (1) | DK1696931T3 (de) |
ES (1) | ES2324713T3 (de) |
HK (1) | HK1095092A1 (de) |
IL (1) | IL176447A0 (de) |
MX (1) | MXPA06007244A (de) |
NO (1) | NO20063371L (de) |
NZ (1) | NZ547911A (de) |
PL (1) | PL1696931T3 (de) |
PT (1) | PT1696931E (de) |
SG (1) | SG133606A1 (de) |
SI (1) | SI1696931T1 (de) |
WO (1) | WO2005063254A2 (de) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL151164A0 (en) | 2000-03-06 | 2003-04-10 | Acadia Pharm Inc | Azacyclic compounds for use in the treatment of serotonin related diseases |
KR20100008799A (ko) | 2001-12-28 | 2010-01-26 | 아카디아 파마슈티칼스 인코포레이티드 | 모노아민 수용체 조정자로서의 스피로아자사이클릭 화합물 |
IL164155A0 (en) * | 2002-03-20 | 2005-12-18 | Teva Pharma | Crystalline forms of quetiapine hemifumarate |
AU2003247615B2 (en) | 2002-06-24 | 2007-08-09 | Acadia Pharmaceuticals Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
US7253186B2 (en) | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
US7538222B2 (en) | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
CA2512639C (en) | 2003-01-16 | 2012-10-30 | Acadia Pharmaceuticals Inc. | Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
WO2004064753A2 (en) * | 2003-01-23 | 2004-08-05 | Acadia Pharmaceuticals Inc | Use of n-desmethylclozapine to treat human neuropsychiatric disease |
NZ527142A (en) | 2003-07-23 | 2006-03-31 | Douglas Pharmaceuticals Ltd | A stable suspension formulation |
US20090239840A1 (en) * | 2003-12-22 | 2009-09-24 | Acadia Pharmaceuticals, Inc. | AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS |
WO2008021463A2 (en) * | 2006-08-15 | 2008-02-21 | Acadia Pharmaceuticals, Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
SI1696931T1 (sl) * | 2003-12-22 | 2009-08-31 | Acadia Pharm Inc | Amino substituirani diaril(a,d)cikloheptenski analogi kot muskarinski agonisti in postopki za zdravljenje nevropsihiatričnih motenj |
US20050171088A1 (en) * | 2004-01-30 | 2005-08-04 | Astrazeneca Ab | Treatment of psychoses with dibenzothiazepine antipsychotic |
US20050282800A1 (en) * | 2004-04-01 | 2005-12-22 | Bo-Ragnar Tolf | Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof |
US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
EP2374455A3 (de) | 2004-08-19 | 2012-03-28 | Vertex Pharmaceuticals Incorporated | Modulatoren von muskarinischen Rezeptoren |
US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
US20060081361A1 (en) * | 2004-09-13 | 2006-04-20 | Gabbey Lawrence W | Oil cooler with integral filter |
US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
EP2289879B1 (de) | 2004-09-27 | 2014-11-12 | Acadia Pharmaceuticals Inc. | Synthese einer Kristallform des Tartratsalzes von n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)Carbamid. |
RU2007124373A (ru) * | 2004-11-29 | 2009-01-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецептеров |
JP2008526839A (ja) * | 2005-01-07 | 2008-07-24 | アストラゼネカ・アクチエボラーグ | 11−ピペラジン−1−イルジベンゾ[b,f][1,4]チアゼピン又はその薬学的に許容される塩の新規な使用及び経口医薬組成物への新規な使用 |
WO2006107948A2 (en) * | 2005-04-04 | 2006-10-12 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
CA2603795A1 (en) * | 2005-04-14 | 2006-10-26 | Teva Pharmaceutical Industries Ltd. | Process for preparing quetiapine fumarate |
EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
EP2275095A3 (de) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese durch modulation des Muscarinrezeptors |
WO2007047776A1 (en) * | 2005-10-17 | 2007-04-26 | Acadia Pharmaceuticals Inc. | Iron catalyzed cross-coupling reactions of imidoyl derivatives |
US20070105819A1 (en) * | 2005-10-17 | 2007-05-10 | Roger Olsson | CB-1 modulating compounds and their use |
US20080090805A1 (en) * | 2005-10-17 | 2008-04-17 | Acadia Pharmaceuticals Inc. | Cb-1 modulating compounds and their use |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
WO2007053618A1 (en) * | 2005-10-31 | 2007-05-10 | Acadia Pharmaceuticals Inc. | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
US20070105835A1 (en) * | 2005-11-07 | 2007-05-10 | Kazantsev Aleksey G | Compositions and methods for modulating poly(ADP-ribose) polymerase activity |
US20090069292A1 (en) * | 2005-11-18 | 2009-03-12 | Astrazeneca Ab | Liquid Formulations |
EP1951694A4 (de) * | 2005-11-18 | 2010-09-22 | Astrazeneca Ab | Salzformen |
EP1988892A2 (de) | 2006-02-22 | 2008-11-12 | Vertex Pharmaceuticals Incorporated | Modulatoren muskarinischer rezeptoren |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | 5ht受容体介在性の神経新生 |
WO2007133802A2 (en) * | 2006-05-15 | 2007-11-22 | Acadia Pharmaceuticals Inc. | Pharmaceutical formulations of pimavanserin |
DE102006032427A1 (de) * | 2006-07-13 | 2008-01-17 | Neuraxpharm Arzneimittel Gmbh U. Co. Kg | Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung |
DE102006032426A1 (de) * | 2006-07-13 | 2008-01-17 | Neuraxpharm Arzneimittel Gmbh U. Co. Kg | Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung |
CN101573121A (zh) * | 2006-08-18 | 2009-11-04 | 弗特克斯药品有限公司 | 毒蕈碱受体调节剂 |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2008118141A2 (en) * | 2006-10-17 | 2008-10-02 | Acadia Pharmaceuticals Inc. | Use of cannabinoid modulating compounds in combination with other therapeutic compounds for adjunctive therapy |
CN101622002A (zh) * | 2006-12-20 | 2010-01-06 | 阿斯利康(瑞典)有限公司 | 化合物及其用途 |
EP2120957A4 (de) * | 2006-12-20 | 2011-05-04 | Astrazeneca Ab | Verbindungen und ihre verwendungen |
GB0701970D0 (en) * | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
BRPI0808828A8 (pt) * | 2007-03-15 | 2017-11-28 | Aryx Therapeutics Inc | Compostos de dibenzo[b,f][1,4]oxazapina |
WO2008116024A2 (en) | 2007-03-19 | 2008-09-25 | Acadia Pharmaceuticals Inc. | Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
WO2009045519A1 (en) * | 2007-10-03 | 2009-04-09 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
WO2009149347A1 (en) | 2008-06-05 | 2009-12-10 | President And Fellows Of Harvard College | High-valent palladium fluoride complexes and uses thereof |
ME01516B (me) | 2008-06-20 | 2014-04-20 | Astrazeneca Ab | DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA |
WO2010062565A1 (en) * | 2008-10-27 | 2010-06-03 | Acadia Pharmaceuticals Inc. | Muscarinic agonists |
CA2742869A1 (en) | 2008-11-20 | 2010-05-27 | President And Fellows Of Harvard College | Fluorination of organic compounds |
WO2010081036A2 (en) * | 2009-01-09 | 2010-07-15 | President And Fellows Of Harvard College | Fluorine containing compounds and methods of use thereof |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN101531570B (zh) * | 2009-04-17 | 2012-10-10 | 中国科学院上海有机化学研究所 | 1,2-取代-5-乙炔基-(或10,11-二氢)-5H-二苯基[a,d]环庚烯(烷)-5-醇、合成方法及用途 |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
US20110020423A1 (en) | 2009-07-22 | 2011-01-27 | Puretech Ventures | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
WO2011025748A1 (en) * | 2009-08-26 | 2011-03-03 | Acadia Pharmaceuticals, Inc. | Amino substituted diaryl [a, d] cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
WO2012142162A2 (en) | 2011-04-12 | 2012-10-18 | President And Fellows Of Harvard College | Fluorination of organic compounds |
WO2014052622A1 (en) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Nickel fluorinating complexes and uses thereof |
EP3043790B1 (de) | 2013-09-11 | 2021-05-26 | The Administrators of the Tulane Educational Fund | Neuartige anthranilamide und verwendung davon |
US10759764B2 (en) | 2013-10-18 | 2020-09-01 | President And Fellows Of Harvard College | Fluorination of organic compounds |
CN104016937B (zh) * | 2014-05-09 | 2016-12-07 | 中科院广州化学有限公司 | 一种n-芳基氧氮杂卓酮类化合物及其制备方法 |
TWI698440B (zh) | 2015-07-02 | 2020-07-11 | 瑞士商赫孚孟拉羅股份公司 | 苯并氧氮呯噁唑啶酮化合物及其用途 |
PL3325444T3 (pl) | 2015-07-20 | 2021-12-06 | Acadia Pharmaceuticals Inc. | Sposoby wytwarzania N-(4-fluorobenzylo)-N-(1-metylopiperydyn-4-ylo)-N'-(4-(2-metylopropyloksy)fenylometylo)karbamidu oraz jego soli winianowej i postaci polimorficznej C |
WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
EP3558311A1 (de) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin allein oder in kombination zur verwendung in der behandlung von morbus-alzheimer-psychose |
TW201831462A (zh) * | 2017-01-25 | 2018-09-01 | 日商大日本住友製藥股份有限公司 | 二苯并二氮呯衍生物 |
WO2018148529A1 (en) * | 2017-02-10 | 2018-08-16 | Florida A&M University | Identification of agents displaying functional activation of dopamine d2 and d4 receptors |
US11135211B2 (en) | 2017-04-28 | 2021-10-05 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
US20210077479A1 (en) | 2017-08-30 | 2021-03-18 | Acadia Pharmaceuticals Inc. | Formulations of pimavanserin |
CA3078289A1 (en) | 2017-10-06 | 2019-04-11 | Leyden Technologies B.V. | Stable solutions of multicyclic antidepressants |
CN107903244B (zh) * | 2017-11-29 | 2019-06-14 | 武汉珈创生物技术股份有限公司 | 具有抗肿瘤活性的2-胺基取代苯并二氮卓化合物及其制备方法 |
JP7422666B2 (ja) | 2018-01-30 | 2024-01-26 | アプニメッド,インコーポレイテッド(デラウェア) | 睡眠時無呼吸を治療するための方法および組成物 |
JP2021104931A (ja) * | 2018-02-22 | 2021-07-26 | 大日本住友製薬株式会社 | 含窒素複素環を有するジベンゾアゼピン誘導体 |
CN110627735A (zh) * | 2018-06-25 | 2019-12-31 | 江阴安博生物医药有限公司 | 一种新的喹硫平类似物及其制备方法和应用 |
IL295341A (en) | 2018-09-28 | 2022-10-01 | Karuna Therapeutics Inc | Compositions and methods for the treatment of diseases improved by the activation of muscarinic receptors |
CA3154630A1 (en) | 2019-10-21 | 2021-04-29 | Mark E. Duggan | 3-(4-(11h-dibenzo[b,e][1,4]azepin-6-yl)piperazin-1-yl)- and 3-(4-(dibenzo[b,f][1,4]oxazepin/thiazepin/diazepin-11-yl)piperazin-1-yl)-propano ic acid derivatives as h1 and 5-ht2a-receptor modulators for the treatment of sleep disorders |
CN112358455B (zh) * | 2020-11-16 | 2022-07-19 | 吉林奥来德光电材料股份有限公司 | 一种二苯并七元杂环类化合物及其制备方法与应用 |
TWI820605B (zh) * | 2022-02-18 | 2023-11-01 | 國立臺灣大學 | 抗菌化合物、其製備方法及其用途 |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR870763A (fr) | 1939-12-19 | 1942-03-24 | Zeiss Ikon Ag | Procédé destiné à faire disparaître les bruits produits par les boucles du film dans les appareils de prise de vues et de reproduction, en particulier pour la priseet la reproduction de films sonores |
CH240228A (de) | 1944-07-28 | 1945-12-15 | Ciba Geigy | Schaumisoliermasse auf Kunstharzbasis. |
FR939591A (fr) | 1946-01-09 | 1948-11-18 | Philips Nv | Récepteur de télévision |
FR939595A (fr) | 1947-01-08 | 1948-11-18 | Perfectionnements apportés aux tuiles à recouvrement en matériaux de toute nature | |
FR51M (de) | 1960-06-03 | 1960-11-28 | ||
CH422793A (de) * | 1961-07-20 | 1966-10-31 | Wander Ag Dr A | Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine |
FR1334944A (fr) | 1961-08-11 | 1963-08-16 | Wander Ag Dr A | Procédé de préparation d'amidines de la série des 5-dibenzo-[b,e] [1,4]-diazépines |
DE1620711A1 (de) * | 1962-05-25 | 1970-06-04 | Wander Ag Dr A | Verfahren zur Herstellung 11-basisch substituierter 5H-Dibenzo[b,e][1,4]diazepine |
CH476743A (de) | 1962-06-08 | 1969-08-15 | Wander Ag Dr A | Verfahren zur Herstellung von Amidinen der Dibenzo (b,e) (1,4)-diazepin-Reihe |
NL140242B (nl) * | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
US3389139A (en) | 1963-06-14 | 1968-06-18 | Wander Ag Dr A | 6-homopiperazino and piperazinomorphanthridines |
GB1006156A (en) | 1963-06-14 | 1965-09-29 | Wander Ag Dr A | 6-basic substituted morphanthridines |
US3884920A (en) | 1967-07-14 | 1975-05-20 | Sandoz Ag | 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines |
US3908010A (en) | 1967-03-22 | 1975-09-23 | Wander Ag Dr A | Basically substituted heterocycles as anti-emetics |
AT252925B (de) | 1964-05-27 | 1967-03-10 | Wander Ag Dr A | Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine |
US3412193A (en) | 1965-12-13 | 1968-11-19 | American Cyanamid Co | 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility |
AT278805B (de) | 1966-01-17 | 1970-02-10 | American Cyanamid Co | Verfahren zur herstellung von oxazepinen und thiazepinen |
GB1184251A (en) | 1966-04-15 | 1970-03-11 | American Cyanamid Co | Oxazepines and Thiazepines |
GB1192812A (en) | 1966-05-20 | 1970-05-20 | American Cyanamid Co | 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts |
NL6715650A (de) | 1966-12-16 | 1968-06-17 | ||
GB1177956A (en) | 1966-12-23 | 1970-01-14 | American Cyanamid Co | Production of Oxazepines and Thiazepines |
CA979441A (en) | 1967-02-27 | 1975-12-09 | American Cyanamid Company | 11-(piperazinyl) dibenz (b,f) (1,4) oxazepines and analogous thiazepines |
CH514612A (de) | 1967-03-13 | 1971-10-31 | Wander Ag Dr A | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine |
DE1720007A1 (de) | 1967-03-13 | 1971-05-19 | Wander Ag Dr A | Basisch substituierte Heterocyclen |
US3852446A (en) | 1967-03-13 | 1974-12-03 | Sandoz Ag | Organic compounds in treatment of psychotic disturbances |
US3751415A (en) | 1967-03-22 | 1973-08-07 | Sandoz Ag | 2-nitro-11-(1-piperazinyl)-dibenz(b,f)(1,4)oxazepines |
US3758479A (en) | 1967-03-22 | 1973-09-11 | Sandoz Ag | Nitro and sulphamoyl substituted dibenzodiazepines |
US3539573A (en) | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
CA918659A (en) | 1969-07-31 | 1973-01-09 | Yoshitomi Pharmaceutical Industries | 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines |
NL7110453A (de) | 1970-08-06 | 1972-02-08 | Wander Ag Dr A | |
US3660406A (en) | 1970-10-26 | 1972-05-02 | American Cyanamid Co | 2-chloro-7-hydroxy-11-(1-piperazinyl)dibenz(b f)(1 4)oxazepines |
CH555856A (de) | 1971-05-04 | 1974-11-15 | Hoffmann La Roche | Verfahren zur herstellung von tricyclischen verbindungen. |
US3962248A (en) | 1972-04-04 | 1976-06-08 | Sandoz, Inc. | Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines |
CH569730A5 (de) | 1972-04-04 | 1975-11-28 | Wander Ag Dr A | |
CH585222A5 (en) | 1973-02-14 | 1977-02-28 | Wander Ag Dr A | Prepn. of antipsychotic heterocyclic piperazine derivs. - by reaction of heterocyclic ketones with metal piperazine complexes |
NL7403657A (de) | 1973-03-23 | 1974-09-25 | ||
US3983234A (en) | 1974-07-04 | 1976-09-28 | Sandoz Ltd. | Treatment of dyskinesias |
DE2625258A1 (de) | 1975-06-06 | 1976-12-09 | Hoffmann La Roche | Dibenzo eckige klammer auf b,f eckige klammer zu thiepinderivat |
DE2641378A1 (de) | 1975-09-24 | 1977-04-07 | Sandoz Ag | Neue organische verbindungen, ihre verwendung und herstellung |
US4045445A (en) | 1975-12-14 | 1977-08-30 | American Cyanamid Company | 11-(4-Piperidyl)dibenzo-diazepines |
CS179793B1 (en) | 1976-02-13 | 1977-11-30 | Miroslav Protiva | Biological derivative of 11-/4-methylpiperazino/-5h-dib)nzo/b,e/-1,4-diazepine |
CH601288A5 (en) | 1976-06-09 | 1978-07-14 | Sandoz Ag | 11-Piperazino-5H-di:benzodiazepine derivs. |
CH624682A5 (de) | 1976-11-10 | 1981-08-14 | Sandoz Ag | |
US4406900A (en) | 1976-11-10 | 1983-09-27 | Sandoz Ltd. | Neuroleptic use of morphanthridines |
US4191760A (en) | 1977-02-23 | 1980-03-04 | Abbott Laboratories | Dibenzodiazepines |
US4097597A (en) | 1977-02-23 | 1978-06-27 | Abbott Laboratories | Dibenzo b,e! 1,4!diazepines |
US4096261A (en) * | 1977-02-23 | 1978-06-20 | Abbott Laboratories | Dibenzodiazepines |
DD133235A1 (de) | 1977-10-10 | 1978-12-20 | Carla Rueger | Verfahren zur herstellung von in 11-stellung basisch substituierten 5h-dibenzo eckige klammer auf b,e eckige klammer zu eckige klammer auf 1,4 eckige klammer zu diazepinen |
CS196893B1 (en) | 1977-12-22 | 1980-04-30 | Miroslav Protiva | 3-fluor-10-piperazino-8-substituted 10,11-dihydro-dibenzothiepines |
US4263207A (en) | 1978-08-01 | 1981-04-21 | Merck & Co., Inc. | 10,11-Dihydrodibenzo[b,f][1,4]thiazepine carboxylic acids esters and amides thereof |
US4404137A (en) * | 1979-10-16 | 1983-09-13 | Lilly Industries Limited | Pyrazolo [3,4-b][1,5]benzodiazepine compounds |
US4764616A (en) | 1983-05-18 | 1988-08-16 | Hoechst-Roussel Pharmaceuticals Inc. | Benzopyrrolobenzodiazepines and quinobenzodiazepines |
US4663453A (en) | 1983-05-18 | 1987-05-05 | Hoechst-Roussel Pharmaceuticals Inc. | Benzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepines having dopamine receptor activity |
GB8607684D0 (en) * | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
JPH04211071A (ja) | 1990-03-05 | 1992-08-03 | Hokuriku Seiyaku Co Ltd | 多環式化合物 |
BE1004596A4 (fr) | 1990-09-26 | 1992-12-22 | Therabel Res S A N V | Derives de methylpiperazinoazepine, leur preparation et leur utilisation. |
US5817655A (en) * | 1991-04-23 | 1998-10-06 | Eli Lilly And Company | Methods of treatment using a thieno-benzodiazepine |
US5300422A (en) | 1991-12-04 | 1994-04-05 | Case Western Reserve University | Screening method for controlling agranulocytosis |
US5393752A (en) * | 1992-05-26 | 1995-02-28 | Therabel Research S.A./N.V. | Methylpiperazinoazepine compounds, preparation and use thereof |
WO1994026107A1 (en) | 1993-05-13 | 1994-11-24 | New York University | Psychosis protecting nucleic acid, peptides, compositions and method of use |
US5354747A (en) | 1993-06-16 | 1994-10-11 | G. D. Searle & Co. | 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use |
US5707798A (en) | 1993-07-13 | 1998-01-13 | Novo Nordisk A/S | Identification of ligands by selective amplification of cells transfected with receptors |
US5538965A (en) | 1993-12-23 | 1996-07-23 | Allelix Biopharmaceuticals Inc. | Dopamine receptor ligands |
US6566065B1 (en) | 1994-05-26 | 2003-05-20 | Mcgill University | Method of diagnosing schizophrenia by detecting a mutation in the (MTHFR) gene |
GB2292685A (en) | 1994-07-27 | 1996-03-06 | Sankyo Co | Allosteric effectors at muscarinic receptors |
US5602120A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | Benzyl-substituted compounds having dopamine receptor affinity |
US5700445A (en) | 1994-12-12 | 1997-12-23 | Allelix Biopharmaceuticals, Inc. | N-methyl piperazine compounds having dopamine receptor affinity |
US5602124A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
US5602121A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | Alkyl-substituted compounds having dopamine receptor affinity |
SE9500998D0 (sv) * | 1995-03-19 | 1995-03-19 | Haakan Wilhelm Wikstroem | New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics |
GB9617305D0 (en) | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
DE60109148T2 (de) | 2000-04-28 | 2006-01-05 | Acadia Pharmaceuticals Inc., San Diego | Muscarinrezeptoren |
AU2002249885A1 (en) | 2000-11-17 | 2002-08-12 | Adolor Corporation | Delta agonist analgesics |
US7214673B2 (en) * | 2002-03-28 | 2007-05-08 | Eli Lilly And Company | Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
EP1538906A2 (de) | 2002-09-18 | 2005-06-15 | Fmc Corporation | Insektizide tricyclische derivate |
US20060069083A1 (en) | 2002-12-20 | 2006-03-30 | Gerd Steiner | Pesticidal dibenzo(hetero)azepine derivatives |
US20050250767A1 (en) | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
WO2004064753A2 (en) | 2003-01-23 | 2004-08-05 | Acadia Pharmaceuticals Inc | Use of n-desmethylclozapine to treat human neuropsychiatric disease |
US20070275957A1 (en) | 2003-01-23 | 2007-11-29 | Weiner David M | Use of n-desmethylclozapine to treat human neuropsychiatric disease |
US20050085463A1 (en) | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
WO2004073639A2 (en) | 2003-02-19 | 2004-09-02 | Merck & Co. Inc. | Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
SI1696931T1 (sl) | 2003-12-22 | 2009-08-31 | Acadia Pharm Inc | Amino substituirani diaril(a,d)cikloheptenski analogi kot muskarinski agonisti in postopki za zdravljenje nevropsihiatričnih motenj |
EP1726952A4 (de) | 2004-02-20 | 2008-06-18 | Dainippon Sumitomo Pharma Co | Verfahren zum in-vivo-screening eines therapeutikums für eine gedächtnis-/lernfehlfunktion durch schizophrenie |
US20050282800A1 (en) | 2004-04-01 | 2005-12-22 | Bo-Ragnar Tolf | Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof |
US7592333B2 (en) | 2004-09-21 | 2009-09-22 | Hypnion, Inc. | Loxapine analogs and methods of use thereof |
US20060063754A1 (en) | 2004-09-21 | 2006-03-23 | Edgar Dale M | Methods of treating a sleep disorder |
WO2006107948A2 (en) | 2005-04-04 | 2006-10-12 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
WO2007053618A1 (en) | 2005-10-31 | 2007-05-10 | Acadia Pharmaceuticals Inc. | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
-
2004
- 2004-12-21 SI SI200431143T patent/SI1696931T1/sl unknown
- 2004-12-21 PL PL04815318T patent/PL1696931T3/pl unknown
- 2004-12-21 CN CN2010102389158A patent/CN101962369A/zh active Pending
- 2004-12-21 DE DE602004020263T patent/DE602004020263D1/de active Active
- 2004-12-21 DK DK04815318T patent/DK1696931T3/da active
- 2004-12-21 EP EP04815318A patent/EP1696931B1/de not_active Not-in-force
- 2004-12-21 SG SG200704645-1A patent/SG133606A1/en unknown
- 2004-12-21 ES ES04815318T patent/ES2324713T3/es active Active
- 2004-12-21 PT PT04815318T patent/PT1696931E/pt unknown
- 2004-12-21 MX MXPA06007244A patent/MXPA06007244A/es active IP Right Grant
- 2004-12-21 EP EP09155868A patent/EP2088147A1/de not_active Withdrawn
- 2004-12-21 CA CA002550735A patent/CA2550735A1/en not_active Abandoned
- 2004-12-21 BR BRPI0417749-5A patent/BRPI0417749A/pt not_active IP Right Cessation
- 2004-12-21 NZ NZ547911A patent/NZ547911A/en not_active IP Right Cessation
- 2004-12-21 WO PCT/US2004/043224 patent/WO2005063254A2/en active Application Filing
- 2004-12-21 KR KR1020067014864A patent/KR101157881B1/ko not_active IP Right Cessation
- 2004-12-21 AU AU2004308955A patent/AU2004308955B2/en not_active Ceased
- 2004-12-21 JP JP2006547344A patent/JP2007534656A/ja not_active Withdrawn
- 2004-12-21 US US11/019,555 patent/US7550454B2/en not_active Expired - Fee Related
- 2004-12-21 AT AT04815318T patent/ATE426405T1/de active
-
2006
- 2006-05-03 US US11/417,859 patent/US7517871B2/en not_active Expired - Fee Related
- 2006-05-03 US US11/417,441 patent/US7491715B2/en not_active Expired - Fee Related
- 2006-06-20 IL IL176447A patent/IL176447A0/en unknown
- 2006-07-20 NO NO20063371A patent/NO20063371L/no not_active Application Discontinuation
-
2007
- 2007-03-05 HK HK07102395.0A patent/HK1095092A1/xx not_active IP Right Cessation
- 2007-04-10 US US11/733,476 patent/US7622461B2/en not_active Expired - Fee Related
-
2009
- 2009-06-25 CY CY20091100666T patent/CY1109171T1/el unknown
- 2009-11-18 US US12/621,435 patent/US20100129473A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176447A0 (en) | Amino substituted diaryl [a,d] cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders | |
WO2008021463A3 (en) | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders | |
WO2002074758A3 (en) | Novel amines as histamine-3 receptor ligands and their therapeutic applications | |
ZA200501082B (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
HK1145322A1 (de) | ||
EG23719A (en) | New process for the synthesis of (I S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of I V abradine and addition salts thereof witha pharmaceutically acceptable acid | |
AP2004003123A0 (en) | Thiazole and oxazole derivatives that modulate PPAR activity | |
IL213649A0 (en) | Prodrugs of gabapentin compounds, compositions and their use in the manufacture of a medicament | |
HK1163545A1 (en) | Phenylpropionamide compounds and the use thereof | |
AU2003206413A8 (en) | Substituted amino carboxamides for the treatment of alzheimer's disease | |
PL369776A1 (en) | Process for producing l-amino acid using escherichia | |
EP1449918A4 (de) | Verfahren zur l-aminosäureproduktion mit escherichia | |
WO2004020431A3 (en) | Novel benzoimidazole derivatives useful as antiproliferative agents | |
AU8830801A (en) | Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders | |
AP1791A (en) | Amino acids with affinity for the ?2?-protein. | |
HK1050144A1 (en) | Uses and compositions of nitrate esters for providing sedation. | |
WO2004026258A3 (en) | Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson’s disease | |
WO2003057213A3 (en) | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
TW200511989A (en) | Methods for using amino acids with affinity for the α 2 δ-protein | |
PL1619185T3 (pl) | Pochodna 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepiny lub jej sól | |
BR0308753A (pt) | Método para produzir pseudo-ilhotas | |
PL1716147T3 (pl) | Pochodne diazaspiropiperydyny jako inhibitory transportera 1 glicyny i transportera 2 glicyny | |
FR2870732A1 (fr) | Composition pour le traitement de matieres keratiniques comprenantun compose polycarboxylique particulier et un polymere cationique et procedes la mettant en oeuvre | |
CA2387394A1 (en) | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder | |
ITPO20020002A1 (it) | Macchina perfezionata per la produzione di catene "gourmette" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121221 |